Duration of Unscheduled Bleeding with DMPA

Expected Bleeding Pattern Timeline

Bleeding patterns typically improve with continued DMPA use, as amenorrhea becomes increasingly common over time, according to the Centers for Disease Control and Prevention 1, 2

Before initiating DMPA, the American College of Obstetricians and Gynecologists recommends counseling patients that amenorrhea and unscheduled spotting or light bleeding are common, and these bleeding irregularities are generally not harmful and will likely decrease with continued use 1, 3

If unscheduled bleeding develops, the Centers for Disease Control and Prevention recommends first ruling out underlying gynecological problems including medication interactions, sexually transmitted infections, pregnancy, or new pathologic uterine conditions such as polyps or fibroids 1, 3
For unscheduled spotting or light bleeding, the American College of Obstetricians and Gynecologists recommends NSAIDs for 5-7 days during active bleeding episodes as first-line treatment 1, 3
For heavy or prolonged bleeding, the American College of Obstetricians and Gynecologists recommends NSAIDs remain first-line (5-7 days), with hormonal treatment using low-dose combined oral contraceptives or estrogen for 10-20 days as second-line if the patient is medically eligible 1, 3

If bleeding persists despite treatment and the patient finds it unacceptable, the Centers for Disease Control and Prevention recommends counseling on alternative contraceptive methods such as long-acting reversible contraceptives (IUDs or implants) and offering another method if desired 1, 3

Enhanced counseling about expected bleeding patterns before DMPA initiation has been shown to reduce discontinuation rates, according to Praxis Medical Insights 3